SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings report is the dominant focus, with traders watching managements outlook on subscriber engagement, growth and advertising amid a steep share-price decline. Views are split: bears fear continued weakness and content concerns, while bulls argue expectations are low and a solid outlook could support a rebound.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea is selling off amid trader concerns that its planned Sea Cloud launch and a potential Monee public listing could add uncertainty and spending pressure while Shopee faces subsidy competition from TikTok Shop and Temu. The community is divided over whether the decline is an overreaction to those plans or a sign of deeper competitive and profitability concerns.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is drawing attention as traders anticipate the 80-event trigger for final analysis of SELLASs Phase 3 REGAL trial; the last disclosed count cited in the discussion was 78. CEO Angelos Stergious anniversary message has also fueled unconfirmed buyout speculation, while skeptics stress that no trial update or deal is confirmed and attribute the rebound to trading and biotech-sector strength.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook have been overshadowed by a sharp selloff, with traders pointing to rising costs, weaker cash conversion, and an insurance-business loss as concerns about profitability. The reaction has frustrated bullish holders, while others see the pullback as a buying opportunity and note that strong orders and demand remain intact.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Anticipation of Sareptas DM1 and FSHD siRNA data is driving discussion, with traders pointing to positive Arrowhead results and Sareptas preclinical DM1 findings as support for the platform. Others caution that optimism and suspected short covering are not substitutes for human readouts, and debate whether the share move reflects company-specific momentum or broader biotech strength.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a way to strengthen the balance sheet and refocus on oncology. Others are cautious that the divestiture also removes a significant revenue stream from a company already facing business and profitability concerns.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new buyback were overshadowed by a narrowed full-year profit outlook with the midpoint unchanged, prompting a sharp selloff. Traders are divided between buying the dip on stronger cash-flow prospects and seeing the guidance as a reason for the stocks decline.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports attention is centered on Phase 2 results for RAP-219 in bipolar mania, which traders say met the primary and secondary endpoints and prompted bullish reactions and analyst upgrades. The response is divided: skeptics question the modest efficacy signal and point to agitation events and higher discontinuations, while shares have shown sharp volatility after the initial enthusiasm.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans strong third-quarter results, raised 2026 earnings outlook and record backlog are driving the move higher. Traders are broadly bullish on the earnings and defense-demand outlook, though some are watching whether the shares can hold their gains after the jump.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

COMPs sharp rally has sparked breakout and short-squeeze speculation, with traders pointing to bullish chart patterns and the tokens limited supply. Some see it as a catch-up move after prolonged underperformance, while others remain skeptical and want a clearer catalyst; the institutional push and planned V4 are cited as longer-term bullish context.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PLTR Stock Gains After Palantir Expands Federal Push With Knox Systems Partnership

The move appears tied primarily to Palantirs partnership with Knox Systems to speed deployment of commercial software in secure U.S. government and defense environments, including FedRAMP and IL5 settings; Knox says it can obtain FedRAMP authorization in 90 days or less. A broader rebound in AI stocks after a week-long selloff may also have supported sentiment.

Cathie Wood Buys $8.1 Million of CoreWeave Stock as Goldman Sachs Upgrades, Ark Invest Sells Palantir Stock

Cathie Wood's Ark bought CoreWeave shares and sold Palantir shares on Monday, Oct. 19, 2026.read more...

Nasdaq 100 Sees Best Day In Nearly A Month As AI Rout Cools — AMZN, BE, CRWV, AAPL, PLTR In Focus

Equity

The Philadelphia Semiconductor Index added about 1.6%.


Palantir Stock Is Near a Record High. Should Investors Sell?

Key PointsPalantir's exceptional growth supports the bullish case...

PLTR Stock Gains After Palantir Expands Federal Push With Knox Systems Partnership 

The partnership combines Palantir’s accredited infrastructure with Knox’s process for accelerating federal cloud authorization.


Palantir Partners With Knox System For Customer Support With Missions In FedRAMP

(RTTNews) - On Monday, Knox Systems, a major provider of managed cloud services for U.S. federal agencies and the Department of War, announced a partnership with Palantir Technologies (PLTR) to support customers with critical missions in FedRAMP and IL5 environments...

Zacks Market Edge Highlights: Palantir Technologies, BP, Palo Alto Networks, Visa and AbbVie

Palantir, BP, Palo Alto Networks, Visa and AbbVie are defying market gloom with strong share gains, earnings growth forecasts and distinct opportunities across key sectors.

Knox and Palantir Partner to Further Accelerate Delivery of Software through Largest Federal Cloud

Knox Systems, among the world's largest Federal and Department of War (DoW) Managed Cloud, today announced a new partnership with Palantir Technologies Inc. (NASDAQ: PLTR) focused on customers with critical mission sets in FedRAMP and IL5 environments.With this move, Palantir is doubling down on...

Is Palantir Stock a Buy Right Now?

Key PointsPalantir's stock has generated an 18-bagger gain since its public debut...

Benzinga Bulls and Bears: Palantir, Apple, Six Flags

Benzinga examined the prospects for many investors' favorite stocks over the last week here's a look at some of our top stories.read more...

Cathie Wood-Led Ark Invest's Biggest Q3 Winners And Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Bearish Sentiment

<ul class="summary-bullets"><li>The S&amp;P 500 ended Monday 0.4% higher, the Nasdaq 100 added 1.2%, and the Dow Jones Industrial Average slipped 0.1%.</li><li>CoreWeave extended last week’s weakness, down 0.4%.</li><li>Meta Platforms and Tesla are scheduled to report earnings this week.</li></ul><p>The Nasdaq 100 recorded its best day in nearly a month on Monday as investors returned to the AI play following a week-long rout that sent most AI infrastructure stocks tumbling.&nbsp;</p><p>The S&amp;P 500 ended Monday 0.4% higher, the Nasdaq 100 added 1.2%, and the Dow Jones Industrial Average slipped 0.1%. The Russell 2000, which tracks small-cap stocks, ended 0.3% higher.</p><p>Dow Jones Industrial Average futures traded 56 points higher, or 0.1%. S&amp;P 500 futures climbed 0.1%, and Nasdaq-100 futures were up as well at the time of writing.</p><p>The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) rose 0.4%, and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF</a> (DIA) was flat. Meanwhile, the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) added 1.2% on Monday.&nbsp;&nbsp;</p><p>Meanwhile, the VanEck Semiconductor ETF (<a href="https://stocktwits.com/symbol/SMH">SMH</a>) and the iShares Semiconductor ETF gained little over 2% amid gains in Micron Tech (MU), Nvidia (NVDA), Broadcom (AVGO), and most other silicon makers. The broader Vanguard Information Technology ETF (VGT) dropped 1.5%.</p><p>Retail sentiment on Stocktwits for SPY and DIA was ‘bearish’ with ‘high’ message volumes, while sentiment improved to ‘neutral’ from ‘bearish’ for the QQQ.</p><h2 class="st-heading-2"><strong>US Market Drivers</strong></h2><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>-0.1%</td><td>51,966.03&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr><tr><td>S&amp;P 500</td><td>0.4%</td><td>7,690.73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr><tr><td>Nasdaq 100</td><td>1.2%</td><td>29,529.34&nbsp;&nbsp;</td></tr></tbody></table></figure></div><p>The S&amp;P 500 shed almost 2% last week, marking its sharpest seven-day drop since late June. Meanwhile, the Nasdaq dropped 4.5%, breaking a four-week rally.&nbsp;</p><p>Anxieties surrounding the AI trade escalated following CNBC reports that Anthropic generated $16.8 billion in Q3 sales. Although this is up from $11.6 billion in Q2, traders expressed reservations about the sustainability of the AI expansion.</p><p>Corporate bond investors began pulling back from CoreWeave, pushing its credit default swaps into distressed territory.</p><p>Moreover, a report from&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gartner-warns-3-5-trillion-ai-investments-in-jeopardy-as-returns-don-t-justify-neocloud-buildout/cZxoT2NRBuP">Gartner&nbsp;</a>that alarmed that 80% of the neocloud market would cease to exist on account of revenues not justifying current capex spends, added to market anxiety.&nbsp;</p><p>However, tech stocks at large recovered on Monday with the Philadelphia Semiconductor Index (SOX) up about 1.6%.&nbsp;</p><p>Going forward, investor attention will focus on Meta Platforms (META) and Tesla (TSLA) earnings this week to gauge the overall pace of growth in the wider AI space.&nbsp;</p><p>“Results will show whether strong profit growth can restore confidence in the equity rally,” said Mark Haefele at UBS Chief Investment Office told Bloomberg. “We continue to expect resilient growth and earnings to support equities, and see attractive opportunities in quality bonds.”&nbsp;</p><h2 class="st-heading-2"><strong>Key Trending Stocks</strong></h2><p>Bloom Energy share price added about 3% on Monday after Oracle, in a post on X, signaled a fast-paced improvement in data center Project Jupiter.&nbsp;&nbsp;</p><p>Artificial intelligence developer Anthropic PBC is in advanced discussions to acquire roughly $45 billion in computing power from Nvidia-backed cloud infrastructure firm Nscale, Bloomberg reported.&nbsp;</p><p>Amazon.com Inc. (AMZN) share price rose nearly 5% on Monday and was on-track to record its best day in nearly three months after Morgan Stanley reaffirmed its ‘Overweight’ recommendation on the stock and hiked its share price target.&nbsp;&nbsp;</p><p>Apple Inc. (AAPL) on Monday confirmed an Oct. 28 product launch event in Los Angeles, where the company is expected to unveil its first touchscreen MacBook Pro, marking a major shift in its longstanding approach to laptop design.&nbsp;</p><p>Palantir Technologies (PLTR) shares gained in midday trade on Monday after the company announced it had partnered with Knox Systems to help commercial software companies deploy applications in secure U.S. government and defense environments.&nbsp;</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

Traders work on the floor of the New York Stock Exchange (NYSE). (Photo by Spencer Platt/Getty Images)

The Nasdaq 100 recorded its best day in nearly a month on Monday as investors returned to the AI play following a week-long rout that sent most AI infrastructure stocks tumbling.

Apple Inc

Bloom Energy Corp - Ordinary Shares - Class A

CoreWeave Inc

iShares Core S&P 500 ETF

Palantir Technologies Inc

VanEck Semiconductor ETF

Philadelphia Semiconductor Index

iShares Semiconductor ETF

Vanguard S&P 500 ETF

Palantir Technologies (PLTR) stock price, news, forum, discussions, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

PLTR: Palantir Stock Price Today, Premarket and Aftermarket Price, News, Trading Ideas

Right here ($115 - $120)

$110 - $115

 $100 - $110

Under $100

$PLTR is down over 25% year-to-date and sentiment is currently bearish. At what level would you be a buyer? Drop a comment if you would never buy at any level and why.

At what level are you a buyer of Palantir ($PLTR)?

Stocktwits

At what level are you a buyer of Palantir (

Stocktwits Polls

Traders are intensely debating the firm's role as a sovereign AI leader while managing high valuations ahead of key earnings on November 2nd.

The stock is buzzing after announcing a new federal cloud partnership with Knox Systems to accelerate government software deployment.

Heated community arguments are breaking out between long-term holders and short-sellers over trade executions and position sizing.

Technical traders are closely tracking the $195-$200 price levels to see if the stock can sustain its momentum or trigger a corrective drop.

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

PLTR Futures

PLTR Single Stock Futures

PLTR Micro Single Stock Futures